Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 3—March 2012

Research

Seroprevalence of Antibodies against Taenia solium Cysticerci among Refugees Resettled in United States

Seth E. O’NealComments to Author , John M. Townes, Patricia P. Wilkins, John C. Noh, Deborah Lee, Silvia Rodriguez, Hector H. Garcia, and William M. Stauffer
Author affiliations: Oregon Health & Science University, Portland, Oregon, USA (S.E. O’Neal, J.M. Townes); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P.P. Wilkins, J.C. Noh, D. Lee, W.M. Stauffer); Instituto Nacional de Ciencias Neurologicas, Lima, Peru (S. Rodriguez, H.H. Garcia); Universidad Peruana Cayetano Heredia, Lima (H.H. Garcia); University of Minnesota, Minneapolis, Minnesota, USA (W.M. Stauffer)

Main Article

Table 2

Crude and age–sex standardized seroprevalence of antibodies against Taenia solium cysts among refugees resettled in the United States

Variable Burma, n = 499 Laos, n = 502 Bhutan, n = 500 Burundi, n = 500 p value*
Age, y, median (interquartile range) 29 (22–40) 28 (20–47) 30 (22–45) 21 (18–25) <0.01†
Male, no. (%) 273 (54.7) 240 (47.8) 237 (47.4) 234 (46.8) 0.04
Seroprevalence, % (95% CI)
Crude 23.2 (19.5–27.0) 18.3 (14.9–21.7) 22.8 (19.1–26.5) 25.8 (22.0–29.6) 0.04
Age–sex standardized‡ 23.0 (19.1–26.8) 18.3 (14.9–21.7) 22.3 (18.5–26.0) 27.4 (22.8–32.0) <0.01

*Pearson χ2 unless otherwise noted.
†Kruskall-Wallis χ2.
‡Direct standardization method.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO